Clinical Roundup Patient-reported outcomes indicate improved physical function for complete responders in phase II/III bladder cancer study February 16, 2024Vol.50 No.07
Clinical Roundup Plant-based diet tied to improved sexual health during prostate cancer treatment February 16, 2024Vol.50 No.07
Clinical Roundup Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics February 16, 2024Vol.50 No.07
Clinical Roundup ACS CAN survey finds affordability is the leading policy priority for cancer patients and survivors February 16, 2024Vol.50 No.07
Clinical Roundup Subcutaneous Opdivo shows noninferiority vs. intravenous Opdivo in advanced or metastatic RCC February 02, 2024Vol.50 No.05
Clinical Roundup Global cancer burden grows amid mounting need for services February 02, 2024Vol.50 No.05
Clinical Roundup Anti-cancer compound goes beyond current BTK inhibitors in CLL, other blood cancers February 02, 2024Vol.50 No.05
Clinical Roundup Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas February 02, 2024Vol.50 No.05
Clinical Roundup Rice study finds checkpoint inhibitor that could help treat breast cancer bone metastases February 02, 2024Vol.50 No.05
Clinical Roundup Long-term follow-up pinpoints side effects of prostate cancer treatments January 26, 2024Vol.50 No.04
